Central Admixture Pharmacy Services Recalls Pediatric TPN Bags
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Central Admixture Pharmacy Services Inc is recalling two patient-specific pediatric TPN bags due to incorrect product formulation.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 18, 2026 and geographically references Georgia. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Central Admixture Pharmacy Services Inc initiated a voluntary recall due to incorrect product formulation.
Which Products Are Affected
Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection. Distributed in GA only. Affected lots: 20-1535990-0-1 & 20-1535892-0-1, Exp. Date 16 July 2026. Quantity: (2) patient-specific TPN prescriptions. Recall number D-0740-2026.
What You Should Do
Contact Central Admixture Pharmacy Services, Inc., Atlanta at (844) 903-6418.
Why This Matters
The recall affects two patient-specific prescriptions distributed only in Georgia.
Source
FDA recall D-0740-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (743 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to August 18, 2026.
Frequently Asked Questions
Common questions about this FDA recall.